Sansure Biotech Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 2,028.323 million compared to CNY 2,100.011 million a year ago. Operating income was CNY 1,320.296 million compared to CNY 1,454.821 million a year ago. Net income was CNY 1,120.891 million compared to CNY 1,231.788 million a year ago. Basic earnings per share from continuing operations was CNY 2.8 compared to CNY 3.42 a year ago.